yoteki

FDA Panel to Review Grail's Galleri Cancer Detection Test

STAT News · first seen 10.08.2026

An FDA advisory panel is set to evaluate Grail's multi-cancer early detection test, Galleri, amid broader shifts in biotech innovation and radiopharmaceuticals.

Sources

Also in the feed that day